Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Adductor Canal Block in TKA
NCT04155983Phase 4Unknown
- Sponsor
- Carilion Clinic
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in osteoarthritis (OA) (2 arms), sponsored by Carilion Clinic. Primary endpoint: Narcotic Consumption at 48 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04155983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155983.